Perspective Therapeutics, Inc. held its adjourned Annual Meeting of Stockholders to announce the second adjournment to January 27, 2023, with no other business conducted. The meeting was adjourned solely with respect to voting on Proposal One, which is to approve an amendment to the Company's Certificate of Incorporation to increase the total number of authorized shares of Common Stock to 750,000,000 shares.